PD
TNYA icon

Point72 (DIFC)’s Tenaya Therapeutics TNYA Stock Holding History

Point72 (DIFC)’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$901 Sell
556
-200
-26% -$201 ﹤0.01% 1055
2025
Q2 		$462 Sell
756
-10,272
-93% -$5.23K ﹤0.01% 1466
2025
Q1 		$6.29K Buy
+11,028
New +$10.9K ﹤0.01% 1505
2024
Q4 		– Sell
-4,681
Closed -$9.03K – 1903
2024
Q3 		$9.03K Buy
+4,681
New +$13.2K ﹤0.01% 1272

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Point72 (DIFC)'s TNYA Position: Q3 2025 in Review

Point72 (DIFC) reduced its Tenaya Therapeutics (TNYA) stake by 26% in Q3 2025, selling an estimated $201 and leaving 556 shares worth $901. The position accounts for ﹤0.01% of the portfolio, ranked #1055.

Point72 (DIFC) first reported a position in TNYA in Q3 2024 and has held it in 4 quarters since. The position peaked at $9.03K in Q3 2024. 91 funds tracked by Wall St. Rank hold TNYA as of Q3 2025.

  • Point72 (DIFC) held 556 shares of Tenaya Therapeutics worth $901 as of Q3 2025.
  • Point72 (DIFC) sold 200 Tenaya Therapeutics shares in Q3 2025, an estimated $201.
  • Tenaya Therapeutics made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1055 holding.
  • Point72 (DIFC) first reported a position in Tenaya Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • Point72 (DIFC)'s Tenaya Therapeutics position peaked at $9.03K in Q3 2024.
  • 91 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.